Apheresis is a process through which one or more blood components are often obtained by processing of blood using an apheresis system. The lasting components are then returned to the donor or patient either during the method or at the top of the method. Additionally, newly approved indications for apheresis treatment like acute disseminated encephalomyelitis, autoimmune haemolytic anaemia, and cardiac neonatal lupus supplement the market growth. Nevertheless, dearth of skilled professionals and complications related to the apheresis procedure are expected to hamper the market growth.
Conversely, growth in demand for plasma-derived pharmaceuticals offer profitable opportunities for the expansion of the market. The marketplace for apheresis is primarily driven by the rising prevalence of chronic diseases and therefore the growing number of trauma and injury cases, the growing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the rise within the number of complex surgical procedures, and therefore the favourable reimbursement for apheresis procedures.
The global Apheresis market is segregated on the basis of Product as Apheresis Disposables and Apheresis Devices. Based on Procedure the global Apheresis market is segmented in Automated blood collection (Donor Apheresis) and Therapeutic Apheresis. Based on Technology the global Apheresis market is segmented in Centrifugation and Membrane Separation.
Based on Application, the global Apheresis market is segmented in Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis, and Other Applications.
The global Apheresis market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Apheresis market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd, Braun Melsungen AG, International Inc., Cerus Corporation, Kaneka Corporation, Kawasumi Laboratories, Inc., Nikkiso Co., Ltd., and others are among the major players in the global Apheresis market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Apheresis Market has been segmented as below:
Apheresis Market, By Product
Apheresis Market, By Procedure
Apheresis Market, By Technology
Apheresis Market, By Application
Apheresis Market, By Region
Apheresis Market, By Company
The report covers:
Report Scope:
The global Apheresis market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Apheresis market share. Major industry players with significant revenue share include Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd, Braun Melsungen AG, International Inc., Cerus Corporation, Kaneka Corporation, Kawasumi Laboratories, Inc., Nikkiso Co., Ltd., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Patient Handling Equipment Market
Minimally Invasive Medical Robotics, Imaging & Visualization Systems & Surgical Instruments Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Apheresis Market, By Product
5.1 Introduction
5.2 Apheresis Disposables
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Apheresis Devices
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Apheresis Market, By Procedure
6.1 Introduction
6.2 Automated blood collection (Donor Apheresis)
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Therapeutic Apheresis
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Apheresis Market, By Technology
7.1 Introduction
7.2 Centrifugation
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Membrane Separation
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Apheresis Market, By Application
8.1 Introduction
8.2 Plasmapheresis
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Plateletpheresis
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Erythrocytapheresis
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Leukapheresis
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Photopheresis
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Other Applications
8.7.1 Market Overview
8.7.2 Market Size and Forecast
9. Apheresis Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Apheresis, By Product
9.2.2 North America Apheresis, By Procedure
9.2.3 North America Apheresis, By Technology
9.2.4 North America Apheresis, By Application
9.3 Europe
9.3.1 Europe Apheresis, By Product
9.3.2 Europe Apheresis, By Procedure
9.3.3 Europe Apheresis, By Technology
9.3.4 Europe Apheresis, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific Apheresis, By Product
9.4.2 Asia-Pacific Apheresis, By Procedure
9.4.3 Asia-Pacific Apheresis, By Technology
9.4.4 Asia-Pacific Apheresis, By Application
9.5 Rest of the World
9.5.1 Rest of the World Apheresis, By Product
9.5.2 Rest of the World Apheresis, By Procedure
9.5.3 Rest of the World Apheresis, By Technology
9.5.4 Rest of the World Apheresis, By Application
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
11.1 Terumo BCT, Inc.
11.2 Fresenius SE & Co. KGaA
11.3 Haemonetics Corporation
11.4 Asahi Kasei Medical Co. Ltd
11.5 Braun Melsungen AG
11.6 International Inc.
11.7 Cerus Corporation
11.8 Kaneka Corporation
11.9 Kawasumi Laboratories, Inc.
11.10 Nikkiso Co., Ltd.
11.11 Haemonetics Corporation
11.12 Fresenius Kabi
11.13 Terumo BCT, Inc.
11.14 Asahi Kasei Medical Co., Ltd.
11.15 HemaCare Corporation
11.16 Kaneka Corporation
11.17 Kawasumi Laboratories Inc.
11.18 Cerus Corporation
11.19 B. Braun Melsungen AG
11.20 Nikkiso Co., Ltd.
The Apheresis Market has been segmented as below:
Apheresis Market, By Product
Apheresis Market, By Procedure
Apheresis Market, By Technology
Apheresis Market, By Application
Apheresis Market, By Region
Apheresis Market, By Company
